Prevalence of Antiphospholipid Syndrome Up for Roma SLE

This article originally appeared here.
Share this content:
Prevalence of Antiphospholipid Syndrome Up for Roma SLE
Prevalence of Antiphospholipid Syndrome Up for Roma SLE

WEDNESDAY, June 14, 2017 (HealthDay News) -- The prevalence and risk of antiphospholipid syndrome (APS) is higher for Roma versus Caucasian systemic lupus erythematosus (SLE) patients, according to a study published online June 7 in the International Journal of Rheumatic Diseases.

Victoria Manzano-Gamero, from the Complejo Hospitalario Universitario de Granada in Spain, and colleagues conducted a cross-sectional study including data from 52 Roma and 98 Caucasian SLE patients consecutively attending six hospitals in Spain. The authors compared socio-demographic characteristics, prevalence of APS, and clinical and analytical features of SLE and ALS between ethnic group.

The researchers found that the risk (odds ratio, 2.56; 95 percent confidence interval, 1.02 to 6.39) and prevalence of APS (28.8 versus 13.3 percent; P = 0.027) were increased in Roma SLE patients. They also had a higher prevalence of abortions (23.5 versus 10.2 percent; P = 0.049). A non-significantly higher prevalence of fetal deaths (14.3 versus 5.1 percent; P = 0.106) and thrombotic events (21.1 versus 12.2 percent; P = 0.160) was seen for Roma SLE patients. Roma patients had significantly higher prevalence of arthritis (75.0 versus 57.1 percent; P = 0.034), while the prevalence of serositis, discoid lesions, oral ulcers, and livedo reticularis were non-significantly higher (P = 0.104, 0.191, 0.218, and 0.374, respectively).

"Prevalence and risk of APS were significantly higher in Roma SLE patients," the authors write. "Furthermore, Roma patients had a significantly higher prevalence of abortions and a non-significant higher prevalence of fetal deaths and thrombotic events."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Zika Does Not Appear to Last in Semen As Long As Thought

Zika Does Not Appear to Last in Semen ...

More research is needed to better inform public health recommendations

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke ...

I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke

Higher Odds of Infection With Reduced Kidney Function

Higher Odds of Infection With Reduced Kidney Function

Study finds excess community-acquired infections incidence in individuals with mild to severe CKD

is free, fast, and customized just for you!

Already a member?

Sign In Now »